Javier Pérez‐Peña

Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers

Javier Pérez‐Peña, Verónica Corrales‐Sánchez, Eitan Amir et al. · Scientific Reports · 2017 · 84 citations · Full text

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

María del Mar Noblejas‐López, Cristina Nieto‐Jiménez, Sara Morcillo García et al. · OncoImmunology · 2019 · 79 citations · Full text

Histocompatibility, Km Plotter, Breast Oncology +21

Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease

María Jesús Oset‐Gasque, María Pilar González, Javier Pérez‐Peña et al. · European Journal of Medicinal Chemistry · 2014 · 54 citations · Full text

Medicinal Chemistry, Alzheimer's Disease, Biochemistry +10

A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors

Javier Pérez‐Peña, János Tibor Fekete, Raquel Páez et al. · Frontiers in Immunology · 2019 · 35 citations · Full text

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer

Verónica Corrales‐Sánchez, María del Mar Noblejas‐López, Cristina Nieto‐Jiménez et al. · Journal of Cellular and Molecular Medicine · 2020 · 33 citations · Full text

Breast Oncology, Chemoprevention Strategy, Cancer Biology +16